Skip to main content
Terri Parker, MD, Oncology, New Haven, CT, Yale-New Haven Hospital

TerriLynnParkerMD

Oncology New Haven, CT

Hematologic Oncology

Assistant Professor, Comprehensive Cancer Center, Yale University School of Medicine

Dr. Parker is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Parker's full profile

Already have an account?

Summary

  • Dr. Terri Parker is an oncologist in New Haven, CT and is affiliated with Yale-New Haven Hospital. She received her medical degree from St. George's University School of Medicine and has been in practice 12 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, and multiple myeloma.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
  • Uconn School Of Medicine
    Uconn School Of Medicine2008 - 2009
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2005 - 2008
  • St. George's University School of Medicine
    St. George's University School of MedicineClass of 2005

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2008 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • David S. Fischer Teaching Award for Outstanding Faculty Teaching and Mentoring of Fellows in Medical Oncology Yale Cancer Center, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Terri L Parker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience
    Terri L Parker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Cutaneous toxicity of pralatrexate in cutaneous and peripheral T-cell lymphoma
    Parker TL, Barbarotta L, Girardi M, and Foss F., American Society of Hematology Annual Meeting, Atlanta, GA, 12/2012

Committees

  • Member, Scientific Protocol Review Committee at Smilow Cancer Hospital 2015 - Present
  • Member, Laboratory Formulary Committee at Yale New Haven Hospital 2014 - Present
  • Member, Smilow Ambulatory Care Committee 2013 - Present
  • Member, Transfusion and Tissue Banking Committee at Yale New Haven Hospital 2013 - Present
  • Member, Faculty Advisory Committee at Yale School of Medicine 2015 - 2017

Professional Memberships

Hospital Affiliations